AUA Annual Meeting | Conference

Presence of AR-V7 in Stromal, Epithelial Tissue Suggests Role in Carcinogenesis

May 16th 2015

The role of androgen receptor variant-7 in patients with early stage prostate cancer is not well characterized but data presented at the 2015 American Urological Association (AUA) Meeting is bringing the discussion into focus.

Dr. Kutikov on Tumor Pathology in Renal Cell Carcinoma

May 16th 2015

Alexander Kutikov, MD, FACS, attending surgeon, urologic oncology, associate professor, urologic oncology, Fox Chase Cancer Center, discusses the understanding of tumor pathology in renal cell carcinoma.

Dr. Crawford on LHRH Agonists and GNRH Antagonists

May 16th 2015

E. David Crawford, MD, professor, urology, radiation oncology, University of Colorado Denver, discusses the differences between an LHRH agonist and a GNRH antagonist.

Dr. Shore on a Long-Term Safety Analysis of the COU-AA-302 Study

May 23rd 2014

Neal D. Shore, MD, FACS, medical director, Carolina Urologic Research Center, Myrtle Beach, discusses a long-term safety analysis of the COU-AA-302 study, which he presented at the 2014 AUA Annual Meeting.

Dr. Kapoor Discusses the Inclusion of Radium-223 in AUA Guidelines for CRPC

May 21st 2014

Deepak A. Kapoor, MD, from Integrated Medical Professionals, PLLC, discusses the inclusion of radium-223 in the AUA guideline for castration resistant prostate cancer (CRPC).

PSA Growth Rate May Help Identify Aggressive Prostate Cancer Early

May 21st 2014

Analysis of trends in prostate-specific antigen (PSA) dynamics suggested that PSA growth rates, as well as the amount of PSA-level increase due specifically to cancer, might offer a means of distinguishing aggressive, potentially fatal prostate cancer from clinically inconsequential tumors.

Dr. Evans Discusses the Subgroup Analysis Results of the PREVAIL Study

May 20th 2014

Christopher P. Evans, MD, professor, chairman, Department of Urology, University of California at Davis School of Medicine, UC Davis Comprehensive Cancer Center, discusses the results of an analysis of patients with and without visceral disease defined as liver and/or lung metastases who participated in the PREVAIL study.

Intermittent Degarelix Effective With Less Metabolic Syndrome Than Hormone Agonists, Studies Suggest

May 20th 2014

Men given the GnRH antagonist degarelix because their PSA level rose after primary therapy fared at least as well on an intermittent medication schedule as on a continuous schedule

Cell-Cycle Gene Test Shows Early Promise in Clear Cell RCC

May 20th 2014

A cell-cycle gene array test demonstrated independent value for predicting metastatic progression after surgery for organ-confined renal cell carcinoma (RCC) of clear cell histology, a retrospective study of patient data showed.

Dr. Crawford on Intermittent Androgen Deprivation With Degarelix

May 20th 2014

E. David Crawford, MD, from University of Colorado at Denver, discusses a study presented at the 2014 AUA Annual Meeting that analyzed intermittent androgen deprivation with degarelix.

ED Therapy May Preserve Function, Penile Length After Prostatectomy

May 19th 2014

Daily treatment with the PDE-5 inhibitor tadalafil (Cialis) led to a significant decrease in loss of penile length among men who had undergone bilateral nerve-sparing radical prostatectomy.

Testicular Self-Examination Cost-Effective Compared with Missed Advanced Cancer

May 19th 2014

Testicular self-examination remains highly cost-effective despite a negative recommendation from the United States Preventive Services Task Force (USPSTF), a cost-utility analysis suggested.

In Dog Study, Prostate Cancer Found With a Whiff and a Woof

May 19th 2014

When it comes to detecting prostate cancer accurately and noninvasively, dogs may be ahead by a nose.

Dr. Aberger Discusses a Cost Analysis of Testicular Self-Examinations

May 18th 2014

Michael Aberger, MD, resident physician, University of Kansas Medical Center, discusses a cost analysis of testicular self-examinations.

Social Media Vital in Marketing Large Urology Practices

May 18th 2014

In the age of social media, simply having a website isn't enough. To keep existing patients and attract new ones, large urology group practices need to build websites that are connected to social media outlets at every turn, said Peter M. Knapp, Jr, MD.

Physical Activity Linked to Lower Risk of Death from Bladder Cancer

May 18th 2014

Self-reported physical activity significantly improved the odds that a person would not die of bladder cancer, a review of a national health information database showed.

Active Surveillance Is No Threat to Prostate Cancer Cure-So Far

May 18th 2014

Prostate cancer patients who chose active surveillance did not compromise their chances of a cure by waiting before they underwent radical prostatectomy, data from a Swedish registry showed.

Dr. Mirza on Hematuria and a Bladder Cancer Diagnosis

May 17th 2014

Moben Mirza, MD, assistant professor of urology at the University of Kansas Medical Center, discusses a study presented at the 2014 AUA Annual Meeting that evaluated gender and race variation in the workup of hematuria.

Dr. Rhee Discusses Workplace Violence in Urology Practices

May 17th 2014

Eugene Y. Rhee, MD, chief of urology, Kaiser Permanente, discusses workplace violence in urology practices.

Dr. Mark Scholz on Advances in Prostate Cancer Imaging

May 10th 2013

Mark C. Scholz, MD, from Prostate Oncology Specialists Inc, describes his excitement over advances in prostate cancer imaging techniques, specifically those involving multiparametric MRI.